Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) MAP3K4 Antibodies:
anti-Human MAP3K4 Antibodies:
anti-Mouse (Murine) MAP3K4 Antibodies:
Go to our pre-filtered search.
IL-21 (show IL17C Antibodies) expression is promoted by MEKK4 in malignant T cells and is associated with progression risk in cutaneous T-cell lymphoma
Mutations in genes such as AKT2 (show AKT2 Antibodies), CCNA1 (show CCNA1 Antibodies), MAP3K4, and TGFBR1 (show TGFBR1 Antibodies), were associated significantly with Epstein-Barr-positive gastric tumors, compared with EBV-negative tumors.
Map3k4 haploinsufficiency is the cause of T-associated sex reversal.
MTK1 was identified in the HER2 (show ERBB2 Antibodies)/HER3 (show ERBB3 Antibodies)-HRG (show NRG1 Antibodies) mediated extracellular acidification and cell migration pathway in breast cancer cells.
MAP3K4 is sufficiently mediate the TGFbeta (show TGFB1 Antibodies)-induced phosphorylation of p38 MAPK (show MAPK14 Antibodies) in MEFs and HaCaT cells.
we have identified a reduced IL-1A response, related to a low MAP3K4 expression and high expression of its inhibitor GSK3beta, identifying a novel key player in Crohn's disease.
For the first time we report a significant association between nicotine dependence and DRD5 (show DRD5 Antibodies), NPY1R (show NPY1R Antibodies) MAP3K4 single nucleotide polymorphism.
The upstream molecule of the TRAIL-induced MAPK (show MAPK1 Antibodies) activation is MEKK (show MAP3K1 Antibodies), as opposed to ASK1 (show MAP3K5 Antibodies), via the mediation of its signal through JNK (show MAPK8 Antibodies)/p38 (show CRK Antibodies) in a caspase-8 (show CASP8 Antibodies)-dependent manner.
CIN85 (show SH3KBP1 Antibodies) binding to a C-terminal motif within hTTP leads to the increased phosphorylation of hTTP, possibly through enhanced association with MEKK4
Axin (show AXIN1 Antibodies) utilizes distinct regions for competitive MEKK1 (show MAP3K1 Antibodies) and MEKK4 binding and JNK (show MAPK8 Antibodies) activation.
MAP3K4 activity controls epithelial-to-mesenchymal transition through the ubiquitination and degradation of HDAC6 (show HDAC6 Antibodies).
by forming a complex with MEKK4 in skeletal muscle fibers, Gadd45a (show GADD45A Antibodies) increases MEKK4 protein kinase (show CDK7 Antibodies) activity, which is both sufficient to induce skeletal muscle fiber atrophy and required for Gadd45a (show GADD45A Antibodies)-mediated skeletal muscle fiber atrophy.
suggest a requirement for GADD45gamma (show GADD45G Antibodies) in promoting MAP3K4-mediated activation of p38 MAPK (show MAPK14 Antibodies) signaling in embryonic gonadal somatic cells for testis determination
MTK1 plays an important role in the regulation of cell death and is also involved in the pathogenesis of heart failure.
During Th1 (show HAND1 Antibodies) differentiation, the GADD45beta (show GADD45B Antibodies)/GADD45gamma (show GADD45G Antibodies)/MEKK4 pathway integrates upstream signals transduced by both T cell receptor and IL12 (show IL12A Antibodies)/STAT4 (show STAT4 Antibodies), leading to augmented interferon-gamma (show IFNG Antibodies) production in a process independent of STAT4 (show STAT4 Antibodies).
MEKK4 plays a critical role in regulating MKK4 (show MAP2K4 Antibodies) activity and apoptotic cell death during neural tube development.
MEKK4 is the MAPK (show MAPK1 Antibodies) kinase kinase for TRAF4 (show TRAF4 Antibodies) regulation of the JNK (show MAPK8 Antibodies) pathway
Hindbrains of exencephalic MEKK4(K1361R) embryos show a striking increase in neuroepithelial cell apoptosis and a dramatic loss of phosphorylation of MKK3 (show MAP2K3 Antibodies) and -6, mitogen-activated protein kinase (show MAPK1 Antibodies) kinases (MKKs (show MKKS Antibodies)) regulated by MEKK4 in the p38 (show CRK Antibodies) pathway.
MEKK4 regulates epithelial-to-mesenchymal transition in the endocardial cushions of the developing heart.
The central core of each mitogen-activated protein kinase (MAPK) pathway is a conserved cascade of 3 protein kinases: an activated MAPK kinase kinase (MAPKKK) phosphorylates and activates a specific MAPK kinase (MAPKK), which then activates a specific MAPK. While the ERK MAPKs are activated by mitogenic stimulation, the CSBP2 and JNK MAPKs are activated by environmental stresses such as osmotic shock, UV irradiation, wound stress, and inflammatory factors. This gene encodes a MAPKKK, the MEKK4 protein, also called MTK1. This protein contains a protein kinase catalytic domain at the C terminus. The N-terminal nonkinase domain may contain a regulatory domain. Expression of MEKK4 in mammalian cells activated the CSBP2 and JNK MAPK pathways, but not the ERK pathway. In vitro kinase studies indicated that recombinant MEKK4 can specifically phosphorylate and activate PRKMK6 and SERK1, MAPKKs that activate CSBP2 and JNK, respectively but cannot phosphorylate PRKMK1, an MAPKK that activates ERKs. MEKK4 is a major mediator of environmental stresses that activate the CSBP2 MAPK pathway, and a minor mediator of the JNK pathway. Two alternatively spliced transcripts encoding distinct isoforms have been described.
mitogen-activated protein kinase kinase kinase 4
, MAP three kinase 1
, MAP/ERK kinase kinase 4
, MAPK/ERK kinase kinase 4
, MEK kinase 4
, MEKK 4
, SSK2/SSK22 MAP kinase kinase kinase, yeast, homolog of
, dJ473J16.1 (mitogen-activated protein kinase kinase kinase 4)
, predicted protein of HQ0412
, T-associated sex reversal
, mitogen activated protein kinase kinase kinase 4